Associated Papers
Common gene mutations in 103 authenticated colorectal cancer cell lines.
Kranjec C et al.
Oncogenesis, 2026
41593049 (PubMed )
Supplement: 41389_2026_599_MOESM2_ESM.xlsx › Supplementary_Table_10
Therapeutic Potential of Translational Readthrough at Disease-Associated Premature Termination Codons From Tumor Suppressor Genes.
Torices L et al.
Iubmb Life, 2025
Novel read through agent: ZKN-0013 demonstrates efficacy in APCmin model of familial adenomatous polyposis.
Graf MR et al.
Journal of Molecular Medicine (berlin, Germany), 2023
Mutation Spectrum of Familial Adenomatous Polyposis Patients in Turkish Population: Identification of 3 Novel APC Mutations.
Arslan Ateş E et al.
The Turkish Journal of Gastroenterology : the Official Journal of Turkish Society of Gastroenterology, 2022
Adenomatous polyposis coli in cancer and therapeutic implications.
Noe O et al.
Oncology Reviews, 2021
Characterization of new-generation aminoglycoside promoting premature termination codon readthrough in cancer cells.
Bidou L et al.
Rna Biology, 2017
A flow cytometry-based reporter assay identifies macrolide antibiotics as nonsense mutation read-through agents.
Caspi M et al.
Journal of Molecular Medicine (berlin, Germany), 2016
Readthrough of premature termination codons in the adenomatous polyposis coli gene restores its biological activity in human cancer cells.
Floquet C et al.
Plos One, 2011
Select a paper to view details